Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Incidence of Disabilities and Organ Failures
4.2.2 High Incidence of Road Accidents Leading to Amputations
4.2.3 Scarcity of Donor Organs
4.2.4 Technological Advancements in the Artificial Organ and Bionics
4.3 Market Restraints
4.3.1 Expensive Procedures
4.3.2 Risk of Compatibility Issues and Malfunctions
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Artificial Organ
5.1.1.1 Artificial Heart
5.1.1.2 Artificial Kidney
5.1.1.3 Cochlear Implants
5.1.1.4 Other Organ Types
5.1.2 Bionics
5.1.2.1 Ear Bionics
5.1.2.2 Orthopedic Bionic
5.1.2.3 Cardiac Bionics
5.1.2.4 Others


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 ABIOMED
6.1.2 Berlin Heart
6.1.3 Medtronic
6.1.4 JARVIK HEART,?INC.
6.1.5 ?ssur
6.1.6 LifeNet Health
6.1.7 Cyberonics Inc.
6.1.8 Getinge AB
6.1.9 Boston Scientific Corporation
6.1.10 Esko Bionics


7 MARKET OPPORTUNITIES AND FUTURE TRENDS